# ANI Pharmaceuticals Inc: filings

ANIP · Nasdaq · CIK 1023024 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/anip.md) · [Financials](/companies/anip/financials.md) · [Filings](/companies/anip/filings.md) · [Insiders](/companies/anip/insiders.md)

## Reports and events: 380 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 650, 8-K 267, 144 105, 10-Q 53, 3 31, CT ORDER 28, SC 13G/A 27, 425 24, CORRESP 24, UPLOAD 22, DEFA14A 20, 424B5 19, 10-K 18, DEF 14A 18, EFFECT 16, SC 13G 15, S-8 14, 4/A 13, SC 13D/A 12, ARS 9, POS AM 9, 424B3 7, S-3 7, 8-K/A 5, SCHEDULE 13G/A 5, PRE 14A 4, SC 13D 4, 5 3, S-4 3, 424B2 2, 8-A12B/A 2, S-3/A 2, S-4/A 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, 10-K/A 1, 3/A 1, AW 1, CERTNAS 1, FWP 1, RW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-24 | 07:01 ET | [8-K](/filings/0001023024-26-000071.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001023024-26-000071 |
| 2026-08-07 | 07:01 ET | [10-Q](/filings/0001023024-26-000069.md) | Quarterly report, period 2026-06-30 | 0001023024-26-000069 |
| 2026-08-07 | 07:00 ET | [8-K](/filings/0001023024-26-000068.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-26-000068 |
| 2026-05-21 | 16:13 ET | [8-K](/filings/0001023024-26-000056.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001023024-26-000056 |
| 2026-05-13 | 08:27 ET | [8-K](/filings/0001023024-26-000054.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-26-000054 |
| 2026-05-08 | 06:58 ET | [10-Q](/filings/0001023024-26-000050.md) | Quarterly report, period 2026-03-31 | 0001023024-26-000050 |
| 2026-05-08 | 06:56 ET | [8-K](/filings/0001023024-26-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-26-000049 |
| 2026-04-09 | 16:12 ET | [DEF 14A](/filings/0001023024-26-000039.md) | Proxy statement, period 2025-12-31 | 0001023024-26-000039 |
| 2026-04-07 | 16:21 ET | [8-K](/filings/0001023024-26-000034.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001023024-26-000034 |
| 2026-03-03 | 07:05 ET | [8-K](/filings/0001023024-26-000017.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-26-000017 |
| 2026-02-27 | 06:59 ET | [10-K](/filings/0001023024-26-000014.md) | Annual report, period 2025-12-31 | 0001023024-26-000014 |
| 2026-02-27 | 06:57 ET | [8-K](/filings/0001023024-26-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-26-000013 |
| 2026-01-12 | 16:15 ET | [8-K](/filings/0001023024-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-26-000005 |
| 2025-12-01 | 06:58 ET | [8-K](/filings/0001023024-25-000113.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000113 |
| 2025-11-10 | 08:45 ET | [8-K](/filings/0001023024-25-000110.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000110 |
| 2025-11-07 | 06:57 ET | [10-Q](/filings/0001023024-25-000108.md) | Quarterly report, period 2025-09-30 | 0001023024-25-000108 |
| 2025-11-07 | 06:54 ET | [8-K](/filings/0001023024-25-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-25-000107 |
| 2025-09-26 | 17:03 ET | [8-K](/filings/0001023024-25-000099.md) | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights | 0001023024-25-000099 |
| 2025-09-08 | 06:57 ET | [8-K](/filings/0001023024-25-000089.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000089 |
| 2025-08-22 | 08:00 ET | [SCHEDULE 13D/A](/filings/0001104659-25-081631.md) | Ownership report, active investor, amended | 0001104659-25-081631 |
| 2025-08-08 | 07:01 ET | [10-Q](/filings/0001023024-25-000082.md) | Quarterly report, period 2025-06-30 | 0001023024-25-000082 |
| 2025-08-08 | 06:56 ET | [8-K](/filings/0001023024-25-000081.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-25-000081 |
| 2025-07-29 | 16:55 ET | [8-K](/filings/0001104659-25-071769.md) | 8.01 Other events | 0001104659-25-071769 |
| 2025-07-23 | 16:26 ET | [8-K](/filings/0001023024-25-000074.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-25-000074 |
| 2025-07-23 | 06:53 ET | [8-K](/filings/0001023024-25-000072.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-25-000072 |
| 2025-06-04 | 07:10 ET | [8-K](/filings/0001023024-25-000058.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000058 |
| 2025-05-23 | 07:00 ET | [8-K](/filings/0001023024-25-000056.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001023024-25-000056 |
| 2025-05-20 | 08:05 ET | [8-K](/filings/0001023024-25-000049.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000049 |
| 2025-05-09 | 06:57 ET | [10-Q](/filings/0001023024-25-000046.md) | Quarterly report, period 2025-03-31 | 0001023024-25-000046 |
| 2025-05-09 | 06:55 ET | [8-K](/filings/0001023024-25-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-25-000044 |
| 2025-05-08 | 09:14 ET | [8-K](/filings/0001104659-25-045937.md) | 8.01 Other events | 0001104659-25-045937 |
| 2025-04-10 | 16:38 ET | [DEF 14A](/filings/0001023024-25-000035.md) | Proxy statement, period 2024-12-31 | 0001023024-25-000035 |
| 2025-03-18 | 07:00 ET | [8-K](/filings/0001023024-25-000024.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-25-000024 |
| 2025-03-14 | 16:10 ET | [8-K](/filings/0001023024-25-000021.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-25-000021 |
| 2025-03-13 | 20:50 ET | [SCHEDULE 13D/A](/filings/0001104659-25-023609.md) | Ownership report, active investor, amended | 0001104659-25-023609 |
| 2025-03-11 | 07:00 ET | [8-K](/filings/0001023024-25-000018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000018 |
| 2025-02-28 | 07:05 ET | [10-K](/filings/0001023024-25-000015.md) | Annual report, period 2024-12-31 | 0001023024-25-000015 |
| 2025-02-28 | 06:55 ET | [8-K](/filings/0001023024-25-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-25-000012 |
| 2025-02-05 | 07:00 ET | [8-K](/filings/0001023024-25-000006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000006 |
| 2025-01-13 | 07:00 ET | [8-K](/filings/0001023024-25-000002.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-25-000002 |
| 2024-11-20 | 07:00 ET | [8-K](/filings/0001023024-24-000106.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001023024-24-000106 |
| 2024-11-08 | 08:01 ET | [10-Q](/filings/0001023024-24-000102.md) | Quarterly report, period 2024-09-30 | 0001023024-24-000102 |
| 2024-11-08 | 06:55 ET | [8-K](/filings/0001023024-24-000100.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-24-000100 |
| 2024-09-20 | 16:03 ET | [8-K](/filings/0001023024-24-000093.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001023024-24-000093 |
| 2024-09-16 | 09:13 ET | [8-K](/filings/0001023024-24-000088.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001023024-24-000088 |
| 2024-08-13 | 16:21 ET | [8-K](/filings/0000950103-24-012144.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-24-012144 |
| 2024-08-08 | 21:51 ET | [8-K](/filings/0000950103-24-011897.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-24-011897 |
| 2024-08-07 | 07:26 ET | [8-K](/filings/0000950103-24-011822.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-24-011822 |
| 2024-08-06 | 06:57 ET | [10-Q](/filings/0001023024-24-000085.md) | Quarterly report, period 2024-06-30 | 0001023024-24-000085 |
| 2024-08-06 | 06:53 ET | [8-K](/filings/0001023024-24-000083.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001023024-24-000083 |

Page 1 of 8. [Older](/companies/anip/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:45 ET. No prices; not investment advice.